Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 22% on Friday after reporting results in a late-stage trial that missed expectations.
Related Posts
Google DeepMind Introduces Omni×R: A Comprehensive Evaluation Framework for Benchmarking Reasoning Capabilities of Omni-Modality Language Models Across Text, Audio, Image, and Video Inputs
Omni-modality language models (OLMs) are a rapidly advancing area of AI that enables understanding and reasoning across multiple data types,…
The Allen Institute for AI (AI2) Releases Tülu 3: A Set of State-of-the-Art Instruct Models with Fully Open Data, Eval Code, and Training Algorithms
The Allen Institute for AI (AI2) has announced the release of Tülu 3, a state-of-the-art family of instruction-following models designed…
Microsoft AI Open Sources TinyTroupe: A New Python Library for LLM-Powered Multiagent Simulation
In recent years, developing realistic and robust simulations of human-like agents has been a complex and recurring problem in the…